Dannielle Byers
Family · Medford, ORNPI 1881005320
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 33.3% of the total. Reporting peaked in 2022 at $181 and has fallen 78.9% since, to $38 in 2024.
Across 17 payments — averaging $22.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$125
- AbbVie$87
- Merck$39
- Axsome Therapeutics, Inc.$38
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$29
- Exact Sciences$26
- plus $31 from 2 others
What the payments were for
- Food & beverage$375100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $125 |
| AbbVie | 4 | $87 |
| Merck | 2 | $39 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $29 |
| Exact Sciences | 1 | $26 |
| AstraZeneca | 1 | $16 |
| Tactile Systems Technology Inc | 1 | $16 |
How this compares
$375 in reported general payments places this provider in the 65th percentile of 1,130 family providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 21 | $22,982 |
| MounjaroTirzepatide | 17 | $19,782 |
| Spiriva RespimatTiotropium Bromide | 11 | $12,253 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 11 | $2,070 |
| Vilazodone Hcl | 25 | $1,940 |
| Atorvastatin Calcium | 74 | $1,668 |
| Levemir FlexpenInsulin Detemir | 11 | $1,641 |
| Tramadol Hcl ErTramadol Hcl | 12 | $1,537 |
| Levothyroxine Sodium | 176 | $1,461 |
| Omeprazole | 83 | $1,306 |
| Celecoxib | 44 | $1,286 |
| ProgesteroneProgesterone, Micronized | 36 | $1,254 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 37 | $1,168 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 29 | $1,124 |
| Pantoprazole Sodium | 18 | $1,081 |
Paid to pharmacies, not to this prescriber.
Other family in Medford
- David ArnopoleMedford$38K
- Denise PartinMedford$7K
- Sarah RobersonMedford$4K
- Jody HaasMedford$3K
- Molly ThompsonMedford$3K
- Heather BascomMedford$3K
- Rachel PangilinanPortland$103K
- Jodeanna SweeneyCentral Point$45K
- Lani DoserPortland$45K
- Heather HermanCorvallis$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.